AI assistant
Sending…
Vera Therapeutics, Inc. — Director's Dealing 2021
May 14, 2021
31944_dirs_2021-05-13_ac4f8f17-e42b-4368-b2ed-8f0d48a60b34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-13
Reporting Person: Lin Celia (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (right to buy) | $3.9396 | 2031-02-22 | Class A Common Stock (230821) | Direct |
Footnotes
F1: 1/4 of the shares subject to the option vest on February 16, 2022, and 1/48 of the shares vest monthly thereafter.
More from Vera Therapeutics, Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25